Company Name, Ticker, Customers, else..

Mirati Therapeutics Inc (NASDAQ: MRTX)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Mirati Therapeutics Inc 's

Name: Mirati Therapeutics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRTX Sales vs. its Competitors Q3 2023

Comparing the current results to its competitors, Mirati Therapeutics Inc reported Revenue increase in the 3 quarter 2023 by 201.97 % year on year, while most of its competitors have experienced contraction in revenues by -5.43 %, achieved in the same quarter.

• List of MRTX Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Mirati Therapeutics Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 30.5 %

<< MRTX Stock Performance Comparisons

<< See the full list of MRTX competitors

Overall company Market Share Q3 2023

Due to outstanding performance in Overall company, revenue grew by 201.97 % Mirati Therapeutics Inc improved its market share, to approximately 0.01 %. << More on MRTX Market Share.

*Market share is calculated based on total revenue.

MRTX's Stock Performance relative to its Competitors

Publicly Traded Peers of Mirati Therapeutics Inc

Bridgebio Pharma Inc
Share Performance

-5.46%

This Quarter

Bridgebio Pharma Inc

Profile

BridgeBio Pharma Inc is a biopharmaceutical company that focuses on developing and commercializing precision medicines for genetic diseases and cancers. Their business model involves identifying and acquiring early-stage drug candidates, conducting clinical trials, and partnering with other companies for commercialization.

More about Bridgebio Pharma Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 12,837.680 mill.	$ 713.069 mill.	$ -702.018 mill.

Cartesian Therapeutics Inc
Share Performance

-23.13%

This Quarter

Cartesian Therapeutics Inc

Profile

More about Cartesian Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 221.269 mill.	$ - mill.	$ -151.312 mill.

Os Therapies Incorporated
Share Performance

-6.21%

Over The Past 5 Days

Os Therapies Incorporated

Profile

OS Therapies develops treatments for osteosarcoma and other solid tumors.

More about Os Therapies Incorporated's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 72.881 mill.	$ - mill.	$ -54.549 mill.

Adagene Inc
Share Performance

-31.06%

This Quarter

Adagene Inc

Profile

Adagene Inc is a biotechnology company that develops novel antibody therapeutics for cancer treatment by leveraging its proprietary Dynamic Precision Library platform. Their business model involves partnering with pharmaceutical companies for the development and commercialization of their products.

More about Adagene Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 172.888 mill.	$ 7.671 mill.	$ -17.609 mill.

Biostax Corp
Share Performance

+100.00%

This Quarter

Biostax Corp

Profile

Biostax Corp. acquires, develops, and commercializes pharmaceutical and biotechnology products.

More about Biostax Corp's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.017 mill.	$ - mill.	$ -1.870 mill.

311 more competitors available

Sources: Mirati Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 26, 2026 8:46 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Mirati Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.